- Citations, last 5 years
- 47
- Works, last 5 years
- 4
- h-index
- 49
- Scientists listed
- 0
- Grants since 2016
- 12
Grants received
2024–2026 · research · R43
Development of a low molecular weight synthetic Vi conjugate vaccine for salmonella typhi
Yawei Ni · Knopp Biosciences (United States) · funded by National Institutes of Health
2024–2026 · research · R43
Development of a low molecular weight synthetic Vi conjugate vaccine for salmonella typhi
Yawei Ni · Knopp Biosciences (United States) · funded by National Institutes of Health
2021–2022 · cooperative agreement · U44
Selective Kv7.2/3 activators for the treatment of neuropathic pain
Lynn Resnick · Knopp Biosciences (United States) · funded by National Institutes of Health
2020–2021 · cooperative agreement · U44
Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders
Michael Bozik · Knopp Biosciences (United States) · funded by National Institutes of Health
2019–2021 · cooperative agreement · U44
Selective Kv7.2/3 activators for the treatment of neuropathic pain
Lynn Resnick · Knopp Biosciences (United States) · funded by National Institutes of Health
2019 · cooperative agreement · U44
Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders
Michael Bozik · Knopp Biosciences (United States) · funded by National Institutes of Health
2019–2022 · contract · N44
Phase II - Advanced Development of a Vaccine for Salmonella Paratyphi A
Yawei Ni · Knopp Biosciences (United States) · funded by National Institutes of Health
2016–2020 · cooperative agreement · U44
Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders
Michael Bozik · Knopp Biosciences (United States) · funded by National Institutes of Health
2016–2021 · cooperative agreement · U44
Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders
Michael Bozik · Knopp Biosciences (United States) · funded by National Institutes of Health
2016–2020 · cooperative agreement · U44
Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders
Michael Bozik · Knopp Biosciences (United States) · funded by National Institutes of Health
2016–2018 · contract · N01
DEVELOPMENT OF A NOVEL SALMONELLA PARATYPHI A VACCINE
Yawei Ni · Knopp Biosciences (United States) · funded by National Institutes of Health
2016–2017 · cooperative agreement · U44
Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders
Michael Bozik · Knopp Biosciences (United States) · funded by National Institutes of Health
